These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
169 related items for PubMed ID: 26846153
21. Norcantharidin is a small-molecule synthetic compound with anti-angiogenesis effect. Chen YJ, Tsai YM, Kuo CD, Ku KL, Shie HS, Liao HF. Life Sci; 2009 Oct 21; 85(17-18):642-51. PubMed ID: 19765597 [Abstract] [Full Text] [Related]
22. Genistein suppressed epithelial-mesenchymal transition and migration efficacies of BG-1 ovarian cancer cells activated by estrogenic chemicals via estrogen receptor pathway and downregulation of TGF-β signaling pathway. Kim YS, Choi KC, Hwang KA. Phytomedicine; 2015 Oct 15; 22(11):993-9. PubMed ID: 26407941 [Abstract] [Full Text] [Related]
23. A small-molecule metastasis inhibitor, norcantharidin, downregulates matrix metalloproteinase-9 expression by inhibiting Sp1 transcriptional activity in colorectal cancer cells. Chen YJ, Chang WM, Liu YW, Lee CY, Jang YH, Kuo CD, Liao HF. Chem Biol Interact; 2009 Oct 30; 181(3):440-6. PubMed ID: 19616522 [Abstract] [Full Text] [Related]
24. Inhibitory effect of norcantharidin on the growth of human gallbladder carcinoma GBC-SD cells in vitro. Fan YZ, Fu JY, Zhao ZM, Chen CQ. Hepatobiliary Pancreat Dis Int; 2007 Feb 30; 6(1):72-80. PubMed ID: 17287171 [Abstract] [Full Text] [Related]
25. HDAC inhibitors induce epithelial-mesenchymal transition in colon carcinoma cells. Ji M, Lee EJ, Kim KB, Kim Y, Sung R, Lee SJ, Kim DS, Park SM. Oncol Rep; 2015 May 30; 33(5):2299-308. PubMed ID: 25813246 [Abstract] [Full Text] [Related]
26. Effector mechanisms of norcantharidin-induced mitotic arrest and apoptosis in human hepatoma cells. Chen YN, Chen JC, Yin SC, Wang GS, Tsauer W, Hsu SF, Hsu SL. Int J Cancer; 2002 Jul 10; 100(2):158-65. PubMed ID: 12115564 [Abstract] [Full Text] [Related]
27. Morin, a flavonoid from Moraceae, suppresses growth and invasion of the highly metastatic breast cancer cell line MDA-MB‑231 partly through suppression of the Akt pathway. Jin H, Lee WS, Eun SY, Jung JH, Park HS, Kim G, Choi YH, Ryu CH, Jung JM, Hong SC, Shin SC, Kim HJ. Int J Oncol; 2014 Oct 10; 45(4):1629-37. PubMed ID: 24993541 [Abstract] [Full Text] [Related]
28. HMGA2 induces transcription factor Slug expression to promote epithelial-to-mesenchymal transition and contributes to colon cancer progression. Li Y, Zhao Z, Xu C, Zhou Z, Zhu Z, You T. Cancer Lett; 2014 Dec 01; 355(1):130-40. PubMed ID: 25218351 [Abstract] [Full Text] [Related]
29. Norcantharidin attenuates epidermal growth factor-induced proliferation, EMT and motility in ARPE-19 cells by modulating the AKT/snail/E-cadherin axis. Chien HW, Chen YS, Wang K, Chiou HL, Yang SF, Hsieh YH. Life Sci; 2022 Dec 15; 311(Pt A):121157. PubMed ID: 36356893 [Abstract] [Full Text] [Related]
30. Effect of norcantharidin on the human breast cancer Bcap-37 cells. Liu D, Shi P, Yin X, Chen Z, Zhang X. Connect Tissue Res; 2012 Dec 15; 53(6):508-12. PubMed ID: 22606958 [Abstract] [Full Text] [Related]
31. Sevoflurane induces apoptosis and inhibits the growth and motility of colon cancer in vitro and in vivo via inactivating Ras/Raf/MEK/ERK signaling. Yang X, Zheng YT, Rong W. Life Sci; 2019 Dec 15; 239():116916. PubMed ID: 31626792 [Abstract] [Full Text] [Related]
32. 1,25(OH)2D3 attenuates TGF-β1/β2-induced increased migration and invasion via inhibiting epithelial-mesenchymal transition in colon cancer cells. Chen S, Zhu J, Zuo S, Ma J, Zhang J, Chen G, Wang X, Pan Y, Liu Y, Wang P. Biochem Biophys Res Commun; 2019 Dec 15; 468(1-2):130-5. PubMed ID: 26523511 [Abstract] [Full Text] [Related]
33. CD44 enhances the epithelial-mesenchymal transition in association with colon cancer invasion. Cho SH, Park YS, Kim HJ, Kim CH, Lim SW, Huh JW, Lee JH, Kim HR. Int J Oncol; 2012 Jul 15; 41(1):211-8. PubMed ID: 22552741 [Abstract] [Full Text] [Related]
34. EGR1-dependent PTEN upregulation by 2-benzoyloxycinnamaldehyde attenuates cell invasion and EMT in colon cancer. Kim J, Kang HS, Lee YJ, Lee HJ, Yun J, Shin JH, Lee CW, Kwon BM, Hong SH. Cancer Lett; 2014 Jul 10; 349(1):35-44. PubMed ID: 24704156 [Abstract] [Full Text] [Related]
35. Chrysin inhibits metastatic potential of human triple-negative breast cancer cells by modulating matrix metalloproteinase-10, epithelial to mesenchymal transition, and PI3K/Akt signaling pathway. Yang B, Huang J, Xiang T, Yin X, Luo X, Huang J, Luo F, Li H, Li H, Ren G. J Appl Toxicol; 2014 Jan 10; 34(1):105-12. PubMed ID: 24122885 [Abstract] [Full Text] [Related]
36. EGCG inhibits transforming growth factor-β-mediated epithelial-to-mesenchymal transition via the inhibition of Smad2 and Erk1/2 signaling pathways in nonsmall cell lung cancer cells. Liu LC, Tsao TC, Hsu SR, Wang HC, Tsai TC, Kao JY, Way TD. J Agric Food Chem; 2012 Oct 03; 60(39):9863-73. PubMed ID: 22957988 [Abstract] [Full Text] [Related]
37. Celecoxib inactivates epithelial-mesenchymal transition stimulated by hypoxia and/or epidermal growth factor in colon cancer cells. Bocca C, Bozzo F, Cannito S, Parola M, Miglietta A. Mol Carcinog; 2012 Oct 03; 51(10):783-95. PubMed ID: 21882253 [Abstract] [Full Text] [Related]
38. Selective Cox-2 inhibitor celecoxib induces epithelial-mesenchymal transition in human lung cancer cells via activating MEK-ERK signaling. Wang ZL, Fan ZQ, Jiang HD, Qu JM. Carcinogenesis; 2013 Mar 03; 34(3):638-46. PubMed ID: 23172668 [Abstract] [Full Text] [Related]
39. Mitogen-activated protein kinase-dependent apoptosis in norcan-tharidin-treated A375-S2 cells is proceeded by the activation of protein kinase C. An WW, Wang MW, Tashiro S, Onodera S, Ikejima T. Chin Med J (Engl); 2005 Feb 05; 118(3):198-203. PubMed ID: 15740647 [Abstract] [Full Text] [Related]